Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares, rose in value, with the stock price down by -0.95% to the previous day’s close as strong demand from buyers drove the stock to $15.71.
Actively observing the price movement in the last trading, the stock closed the session at $15.86, falling within a range of $15.5 and $16.1981. The value of beta (5-year monthly) was 1.514. Referring to stock’s 52-week performance, its high was $672.00, and the low was $6.76. On the whole, TNXP has fluctuated by -4.61% over the past month.
With the market capitalization of Tonix Pharmaceuticals Holding Corp currently standing at about $108.05 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-17.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 11.1M, with a low estimate of 2.5M and a high estimate of 2.6M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 2.55M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TNXP’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of TNXP currently trading nearly -21.29% and 3.76% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 44.81, while the 7-day volatility ratio is showing 8.42% which for the 30-day chart, stands at 17.74%. Furthermore, Tonix Pharmaceuticals Holding Corp (TNXP)’s beta value is 1.62, and its average true range (ATR) is 3.01.
A comparison of Tonix Pharmaceuticals Holding Corp (TNXP) with its peers suggests the former has fared considerably weaker in the market. TNXP showed an intraday change of -0.95% in last session, and over the past year, it shrunk by -96.72%%.
Data on historical trading for Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) indicates that the trading volumes over the past 10 days have averaged 0.87 and over the past 3 months, they’ve averaged 1.70 million. According to company’s latest data on outstanding shares, there are 4.39 million shares outstanding.
Nearly 0.00% of Tonix Pharmaceuticals Holding Corp’s shares belong to company insiders and institutional investors own 2.53% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.92 million shares as on 2025-03-31, resulting in a short ratio of 0.39. According to the data, the short interest in Tonix Pharmaceuticals Holding Corp (TNXP) stood at 1338.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 0.55 million. The stock has fallen by -52.37% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TNXP stock heading into the next quarter.
